文献速递乳腺乳腺X线

AI检出与未检出的乳腺癌在乳腺X线摄影上的长期预后意义:倾向性评分匹配分析

Long-term prognostic implications of AI-detected versus AI-undetected breast cancers on mammography: a propensity score-matched analysis.
PubMed 文献 · Eur Radiol · 2026-04-02

本研究回顾性分析879例浸润性乳腺癌患者的术前乳腺X线摄影,使用FDA批准的AI软件(Lunit INSIGHT MMG v1.1.8.2)判断癌症是否可被AI检出。未调整分析中,AI检出组复发率和死亡率更高,但经倾向性评分匹配调整混杂因素后,AI可检出性与无复发生存期(HR, 1.7; p=0.20)和总生存期(HR, 4.1; p=0.21)均无显著关联,提示AI可能优先检出具有侵袭性生物学特征的肿瘤。

要点

  • AI对乳腺X线摄影中浸润性乳腺癌的检出率为83%。
  • 未调整时AI检出组复发和死亡风险更高,但匹配后无统计学差异。
  • AI可检出性并非独立预后因素,可能反映肿瘤侵袭性生物学特征。

诊断标准与关键数值

  • AI正确识别癌症的比例为83%,AI检出定义为AI正确局部定位癌症,AI未检出定义为AI遗漏或错误定位。
  • 未匹配前AI检出组复发率11% vs 5%(p=0.02),死亡率7% vs 1%(p=0.003),远处复发更常见(p=0.04)。
  • 匹配后无复发生存期HR 1.7(95% CI: 0.8, 3.9; p=0.20),总生存期HR 4.1(95% CI: 0.5, 38.1; p=0.21)。
  • 多变量分析中AI可检出性与无复发生存期无关(HR 1.9; 95% CI: 0.9, 3.8; p=0.07),与总生存期无关(HR 5.5; 95% CI: 0.8, 40.7; p=0.09)。

局限性

  • 回顾性研究设计。
  • 单中心研究。
  • 样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the association between the cancer detectability by artificial intelligence (AI) and long-term survival outcomes in invasive breast cancer.

MATERIALS AND METHODS: This retrospective study analyzed consecutive women diagnosed with invasive breast cancer who underwent preoperative mammography between January and December 2013. Mammograms were analyzed using FDA-cleared AI software (Lunit INSIGHT MMG v1.1.8.2). Cancers were classified as AI-detected if correctly localized by AI, and AI-undetected if AI missed or mislocalized. Propensity score matching was performed using 29 clinical, pathological, and treatment-related covariates. Recurrence-free survival (RFS) and overall survival (OS) were compared using Kaplan-Meier estimates and Cox proportional hazards models.

RESULTS: Among 879 women (mean age ± standard deviation, 50.3 ± 10.2 years), AI correctly identified cancers in 83%. Before matching, the AI-detected group had higher recurrence (11% vs 5%; p = 0.02) and mortality rates (7% vs 1%; p = 0.003). Distant recurrence was also more prevalent in AI-detected cases (p = 0.04). After matching, no differences were observed in RFS (HR, 1.7 [95% CI: 0.8, 3.9]; p = 0.20) or OS (HR, 4.1 [95% CI: 0.5, 38.1]; p = 0.21). AI detectability was not associated with RFS (HR, 1.9 [95% CI: 0.9, 3.8]; p = 0.07) or OS (HR, 5.5 [95% CI: 0.8, 40.7]; p = 0.09) in multivariable analysis.

CONCLUSION: AI-detected breast cancers showed higher recurrence and mortality rates in the unadjusted analysis. However, after adjusting for confounders, AI detectability was not associated with RFS or OS, suggesting that AI may preferentially detect tumors with aggressive characteristics.

KEY POINTS: Question AI-based software for mammography interpretation is increasingly being integrated into practice, but the long-term prognostic implications of breast cancers detected or undetected by AI remain unclear. Findings In this retrospective study, AI detectability was not associated with recurrence-free (HR, 1.7; p = 0.20) or overall survival (HR, 4.1; p = 0.21) after propensity score matching. Clinical relevance AI may be more likely to detect biologically aggressive tumors, rather than directly influencing survival.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Kim HJ, Chae EY, Eom HJ, et al. Long-term prognostic implications of AI-detected versus AI-undetected breast cancers on mammography: a propensity score-matched analysis. Eur Radiol. 2026. PMID: 41927979. doi:10.1007/s00330-026-12493-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。